E. coli’s internal bomb – the toxin-antitoxin system – could be triggered to make bacteria turn on themselves, offering a new target for antimicrobial approaches in drug design.
New research has suggested that a protein involved in Alzheimer’s disease may also be implicated in HIV-associated neurological disorders, suggesting Alzheimer’s therapies may benefit a subset of HIV patients.
New research has identified growth-restoring mutations in ceftriaxone-resistant gonorrhoea strains, providing insight into this bacteria’s evolution and raising concerns over the spread of this ‘superbug’.
With Zika research primarily focusing on in utero infections, new work has used a monkey model to study infants infected in their first year of life, uncovering adverse neurological consequences.
TB and HIV are two intertwined infective challenges for global health and therefore they need to be addressed with an integrated approach.
In this interview, we speak to Dr. Bryan Kraft, an Assistant Professor of Medicine at Duke University, about his research into carbon monoxide as a potential therapy to treat ARDS and the clinical trial for this therapy that is currently underway.
In this interview, take a look behind the scenes of a recent Future Microbiology review on influenza virus infection in pregnancy with author, Lucy Somerville.
Researchers have identified that two flu strains are associated with changes to hippocampal structure and function in female mice alongside memory impairment – posing a threat to healthy brain function.
A new study has revealed that serum IgA antibodies deliver a protective barrier against polymicrobial sepsis in mice, providing us with a further understanding of its role in host protection.
In this editorial, the authors assess the insights that could be provided by PET imaging in evaluating and understanding the progression of neurological sequale in Zika virus.
